Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
{{output}}
After the introduction of trastuzumab, a monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2), the overall survival (OS) among patients with HER2-positive breast cancer has been substantially improved. However, among these patients... ...
